# TOFACITINIB

NDC: 76333-111
Generic name: TOFACITINIB
Labeler / Manufacturer: Orient Pharma Co., Ltd. Yunlin Plant
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260610

FDA application: ANDA219830

## Active ingredients

- TOFACITINIB CITRATE: 11 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76333-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76333-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5617a652-a78e-74b1-e063-6394a90a31c7